Seeing Is Believing
Currently out of the existing stock ratings of Matthew Gillmor, 119 are a BUY (81.51%), 27 are a HOLD (18.49%).
Analyst Matthew Gillmor, currently employed at KEYBANK, carries an average stock price target met ratio of 70.61% that have a potential upside of 18.6% achieved within 188 days.
Matthew Gillmor’s has documented 294 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on INNV, InnovAge Holding Corp at 09-Sep-2026.
Analyst best performing recommendations are on THC (TENET HEALTHCARE).
The best stock recommendation documented was for THC (TENET HEALTHCARE) at 4/6/2020. The price target of $20 was fulfilled within 2 days with a profit of $6.48 (47.93%) receiving and performance score of 239.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Feb-2025
$7.03
$0.01 (0.14%)
$8
1 years 7 months 21 days ago
(12-Feb-2025)
1/14 (7.14%)
$0.13 (1.88%)
51
Buy Since 17-Nov-2020
$7.03
1 years 8 months 24 days ago
(09-Jan-2025)
6/12 (50%)
$0.17 (2.48%)
94
Buy Since 07-Jul-2021
$7.5
$0.48 (6.84%)
$7.5
1 years 8 months 25 days ago
(08-Jan-2025)
6/21 (28.57%)
$0.64 (9.33%)
75
Buy Since 03-Jul-2023
$5.75
1 years 8 months 25 days ago
(08-Jan-2025)
3/11 (27.27%)
$1.71 (42.33%)
51
Buy Since 02-Feb-2023
$16
1 years 8 months 25 days ago
(08-Jan-2025)
2/3 (66.67%)
$1.01 (6.74%)
79
Which stock is Matthew Gillmor most bullish on?
Which stock is Matthew Gillmor most reserved on?
What Year was the first public recommendation made by Matthew Gillmor?